Clinical Trial Update: Dust Mite Allergen Reduction Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on dust mite allergen reduction completed, sponsored by NIEHS, investigating allergy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Allergy | Phase 2 | Status: COMPLETED